MRI of the Colon in the Pharmaceutical Field: The Future before us.

MRI flow gut large bowel large intestine magnetic resonance imaging motility transit volume

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
27 Mar 2019
Historique:
received: 28 02 2019
revised: 22 03 2019
accepted: 22 03 2019
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 3 4 2019
Statut: epublish

Résumé

Oral solid drug formulation is the most common route for administration and it is vital to increase knowledge of the gastrointestinal physiological environment to understand dissolution and absorption processes and to develop reliable biorelevant in vitro tools. In particular, colon targeted drug formulations have raised the attention of pharmaceutical scientists because of the great potential of colonic drug delivery. However, the distal bowel is still a relatively understudied part of the gastrointestinal tract. Recently, magnetic resonance imaging (MRI) has been gaining an emerging role in studying the colon. This article provides a comprehensive; contemporary review of the literature on luminal MRI of the colonic environment of the last 15 years with specific focus on colon physiological dimensions; motility; chyme and fluids; transit and luminal flow. The work reviewed provides novel physiological insight that will have a profound impact on our understanding of the colonic environment for drug delivery and absorption and will ultimately help to raise the in vitro/in vivo relevance of computer simulations and bench models.

Identifiants

pubmed: 30934716
pii: pharmaceutics11040146
doi: 10.3390/pharmaceutics11040146
pmc: PMC6523257
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Invest Radiol. 2005 Nov;40(11):689-94
pubmed: 16230900
Aliment Pharmacol Ther. 2005 Nov 15;22(10):971-9
pubmed: 16268972
Neurogastroenterol Motil. 2006 Sep;18(9):805-12
pubmed: 16918759
Eur Radiol. 2007 Mar;17(3):669-74
pubmed: 17036156
Mol Pharm. 2009 Jan-Feb;6(1):60-73
pubmed: 19183105
Radiographics. 2010 Jan;30(1):185-99
pubmed: 20083593
Abdom Imaging. 2011 Feb;36(1):24-30
pubmed: 20151304
Neurogastroenterol Motil. 2011 May;23(5):399-407
pubmed: 21276139
Magn Reson Med. 2011 Sep;66(3):812-20
pubmed: 21381105
Curr Opin Microbiol. 2012 Feb;15(1):57-62
pubmed: 22177113
Inflamm Bowel Dis. 2012 Oct;18(10):1825-34
pubmed: 22223472
Aliment Pharmacol Ther. 2012 Jul;36(1):64-73
pubmed: 22582872
Trials. 2013 Jan 09;14:10
pubmed: 23302220
Eur J Pharm Sci. 2014 Jun 16;57:342-66
pubmed: 23988843
Toxicol Pathol. 2014 Jan;42(1):67-81
pubmed: 24129758
Neurogastroenterol Motil. 2014 Jan;26(1):124-30
pubmed: 24131490
Neurogastroenterol Motil. 2014 Feb;26(2):205-14
pubmed: 24165044
Eur J Pharm Sci. 2014 Jun 16;57:292-9
pubmed: 24189462
Am J Gastroenterol. 2014 Jan;109(1):110-9
pubmed: 24247211
J Magn Reson Imaging. 2015 Feb;41(2):354-60
pubmed: 24399576
Scand J Gastroenterol. 2014 Jun;49(6):681-9
pubmed: 24694282
Neurogastroenterol Motil. 2014 Oct;26(10):1426-36
pubmed: 25060551
Neurogastroenterol Motil. 2014 Dec;26(12):1686-93
pubmed: 25271767
Eur Radiol. 2015 Jun;25(6):1579-87
pubmed: 25576231
Neurogastroenterol Motil. 2015 Apr;27(4):542-9
pubmed: 25703609
Abdom Imaging. 2015 Jun;40(5):975-92
pubmed: 25920487
Pharm Res. 2015 Oct;32(10):3338-49
pubmed: 26002744
Abdom Imaging. 2015 Oct;40(7):2232-41
pubmed: 26054979
Br J Nutr. 2016 Jan 14;115(1):55-61
pubmed: 26522233
Clin Imaging. 2016 Jan-Feb;40(1):90-5
pubmed: 26526527
Neurogastroenterol Motil. 2015 Dec;27(12):1755-63
pubmed: 26598050
Neurogastroenterol Motil. 2016 Mar;28(3):327-35
pubmed: 26612075
Eur J Gastroenterol Hepatol. 2016 May;28(5):514-24
pubmed: 26795566
Neurogastroenterol Motil. 2016 Jun;28(6):861-70
pubmed: 26871949
Am J Clin Nutr. 2016 May;103(5):1318-26
pubmed: 27099247
BMC Med Imaging. 2016 May 05;16(1):37
pubmed: 27149857
Neurogastroenterol Motil. 2017 Feb;29(2):null
pubmed: 27545449
Gastroenterology. 2017 Jan;152(1):124-133.e2
pubmed: 27746233
Jpn J Radiol. 2016 Dec;34(12):809-819
pubmed: 27757786
Am J Gastroenterol. 2017 Feb;112(2):346-355
pubmed: 27958282
Neurogastroenterol Motil. 2017 Jun;29(6):null
pubmed: 28150365
Handb Exp Pharmacol. 2017;239:1-16
pubmed: 28176047
Dis Colon Rectum. 2017 Apr;60(4):385-392
pubmed: 28267005
Neurogastroenterol Motil. 2017 Sep;29(9):null
pubmed: 28439942
Mol Pharm. 2017 Aug 7;14(8):2629-2638
pubmed: 28648070
Colorectal Dis. 2017 Sep;19(9):O350-O357
pubmed: 28688203
ANZ J Surg. 2018 Jun;88(6):E498-E502
pubmed: 28803449
Neurogastroenterol Motil. 2018 Jan;30(1):null
pubmed: 28857333
J Neurogastroenterol Motil. 2018 Jan 30;24(1):119-127
pubmed: 29291613
Dig Dis Sci. 2018 May;63(5):1102-1122
pubmed: 29549474
JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1342-1348
pubmed: 29603286
PLoS One. 2018 Jul 26;13(7):e0201410
pubmed: 30048547
Neurogastroenterol Motil. 2018 Sep;30(9):e13400
pubmed: 30062794
Abdom Radiol (NY). 2019 Jan;44(1):22-30
pubmed: 30066168
Br J Radiol. 2018 Oct 24;:20180433
pubmed: 30299989
Aliment Pharmacol Ther. 2019 Mar;49(6):759-768
pubmed: 30706488
Gastroenterology. 1969 May;56(5):966-71
pubmed: 5782306
Biopharm Drug Dispos. 1995 Jul;16(5):351-80
pubmed: 8527686

Auteurs

Sarah Sulaiman (S)

Nottingham Digestive Diseases Centre and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK. msxss56@nottingham.ac.uk.

Luca Marciani (L)

Nottingham Digestive Diseases Centre and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK. luca.marciani@nottingham.ac.uk.

Classifications MeSH